Xu K, Wang P L, Xu X, et al. An overview on structural modifications of ligustrazine and biological evaluation of its synthetic derivatives[J]. Res Chem Intermediat, 2013, doi:10.1007/s11164-013-1281-2.
[3]
Wang P L, Cheng Y T, Xu K, et al. Synthesis and anti-tumor evaluation of one novel tetramethylpyrazine-rhein derivative[J]. Asian J Chem, 2013, 25(9): 4885.
[4]
Chen H F, Li G N, Zhan P, et al. Design, synthesis and biological evaluation of novel ligustrazinyloxy-cinnamic acid derivatives as potent cardiovascular agents[J]. Eur J Med Chem, 2011, 46: 5609.
[5]
Wang P L, Zhang Y Z, Xu K, et al. A new ligustrazine derivative-pharmacokinetic evaluation and antitumor activity by suppression of NF-κB/p65 and COX-2 expression in S180 mice[J]. Die pharmazie, 2013, 68(9): 782.
Vaudry D, Stork P J S, Lazarovici P, et al. Signaling pathways for PC12 cell differentiation: making the right connections [J]. Science, 2002, 5573 (296): 1648.
[10]
Klesse L J, Meyers K A, Marshall C J, et al. Nerve growth factor induces survival and differentiation through two distinct signaling cascades in PC12 cells[J]. Oncogene, 1999, 18(12): 2055.
Li Z Y, Yu F, Cui L, et al. Design, synthesis and evaluation of novel ligustrazinyl acylguanidine derivatives as potential cardiovascular agents[J]. Med Chem, 2012, 8(5):928.
[19]
Wang P L, Zhang H G, Chu F H, et al. Synthesis and protective effect of new ligustrazine-benzoic acid derivatives against CoCl2 induced neurotoxicity in differentiated PC12 cells[J]. Molecules, 2013, 18(10): 13027.
[20]
Wang P L, She G M, Yang Y N, et al. Synthesis and biological evaluation of new ligustrazine derivatives as anti-tumor agents[J]. Molecules, 2012, 17(5): 4972.
